177 related articles for article (PubMed ID: 15964579)
1. Fabrication of double-walled microspheres for the sustained release of doxorubicin.
Tan EC; Lin R; Wang CH
J Colloid Interface Sci; 2005 Nov; 291(1):135-43. PubMed ID: 15964579
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin-loaded discs and microspheres and their modifications: characterization and in vitro release.
Naraharisetti PK; Lew MD; Fu YC; Lee DJ; Wang CH
J Control Release; 2005 Feb; 102(2):345-59. PubMed ID: 15653156
[TBL] [Abstract][Full Text] [Related]
3. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres.
Pollauf EJ; Berkland C; Kim KK; Pack DW
Int J Pharm; 2005 Sep; 301(1-2):294-303. PubMed ID: 16051452
[TBL] [Abstract][Full Text] [Related]
4. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
5. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
6. Development of highly porous large PLGA microparticles for pulmonary drug delivery.
Yang Y; Bajaj N; Xu P; Ohn K; Tsifansky MD; Yeo Y
Biomaterials; 2009 Apr; 30(10):1947-53. PubMed ID: 19135245
[TBL] [Abstract][Full Text] [Related]
7. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
8. Improvement of gentamicin poly(D,L-lactic-co-glycolic acid) microspheres for treatment of osteomyelitis induced by orthopedic procedures.
Virto MR; Elorza B; Torrado S; Elorza Mde L; Frutos G
Biomaterials; 2007 Feb; 28(5):877-85. PubMed ID: 17064761
[TBL] [Abstract][Full Text] [Related]
9. Study of gamma-irradiation effects on aciclovir poly(D,L-lactic-co-glycolic) acid microspheres for intravitreal administration.
Martínez-Sancho C; Herrero-Vanrell R; Negro S
J Control Release; 2004 Sep; 99(1):41-52. PubMed ID: 15342179
[TBL] [Abstract][Full Text] [Related]
10. In vitro characteristics of poly(lactic-co-glycolic acid) microspheres incorporating gelatin particles loading basic fibroblast growth factor.
Li SH; Cai SX; Liu B; Ma KW; Wang ZP; Li XK
Acta Pharmacol Sin; 2006 Jun; 27(6):754-9. PubMed ID: 16723096
[TBL] [Abstract][Full Text] [Related]
11. Local delivery of doxorubicin for malignant glioma by a biodegradable PLGA polymer sheet.
Manome Y; Kobayashi T; Mori M; Suzuki R; Funamizu N; Akiyama N; Inoue S; Tabata Y; Watanabe M
Anticancer Res; 2006; 26(5A):3317-26. PubMed ID: 17094447
[TBL] [Abstract][Full Text] [Related]
12. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of bioactive doxorubicin from microspheres embedded within gelatin scaffolds.
Defail AJ; Edington HD; Matthews S; Lee WC; Marra KG
J Biomed Mater Res A; 2006 Dec; 79(4):954-62. PubMed ID: 16941588
[TBL] [Abstract][Full Text] [Related]
14. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery.
Giovagnoli S; Blasi P; Schoubben A; Rossi C; Ricci M
Int J Pharm; 2007 Mar; 333(1-2):103-11. PubMed ID: 17079101
[TBL] [Abstract][Full Text] [Related]
15. Preparation of porous PLGA microspheres with thermoreversible gel to modulate drug release profile of water-soluble drug: bleomycin sulphate.
Chaudhari KR; Shah N; Patel H; Murthy R
J Microencapsul; 2010; 27(4):303-13. PubMed ID: 20128747
[TBL] [Abstract][Full Text] [Related]
16. Modified emulsion solvent evaporation method for fabricating core-shell microspheres.
Xiao CD; Shen XC; Tao L
Int J Pharm; 2013 Aug; 452(1-2):227-32. PubMed ID: 23694803
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study.
He Y; Liu Y; Liu Y; Wang J; Zhang X; Lu W; Ma Z; Zhu X; Zhang Q
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3983-8. PubMed ID: 16936114
[TBL] [Abstract][Full Text] [Related]
18. Morphology and release kinetics of technetium-99m(V) dimercaptosuccinic acid loaded, poly(lactic-co-glycolic)acid microspheric delivery system. An experimental approach that may be used for targeted radiation treatment.
Shukla J; Bandopadhyaya GP; Varma IK; Kumar R; Maulik SK
Hell J Nucl Med; 2007; 10(1):9-13. PubMed ID: 17450243
[TBL] [Abstract][Full Text] [Related]
19. Double-walled microspheres loaded with meglumine antimoniate: preparation, characterization and in vitro release study.
Navaei A; Rasoolian M; Momeni A; Emami S; Rafienia M
Drug Dev Ind Pharm; 2014 Jun; 40(6):701-10. PubMed ID: 23594302
[TBL] [Abstract][Full Text] [Related]
20. How autocatalysis accelerates drug release from PLGA-based microparticles: a quantitative treatment.
Siepmann J; Elkharraz K; Siepmann F; Klose D
Biomacromolecules; 2005; 6(4):2312-9. PubMed ID: 16004477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
